AYTU BIOSCIENCE, INC Business Finance Contracts & Agreements
92 Contracts & Agreements
- Credit Agreements (1 contract)
- Exchange Agreements (5)
- Loan Agreements (6)
- Note Agreements (7)
- Purchase Agreements (15)
- Registration Rights Agreements (4)
- Security Agreements (1)
- Stock Agreements (5)
- Subscription Agreements (2)
- Underwriting Agreements (10)
- Waiver Agreements (5)
- Warrant Agreements (31)
- Second Amended and Restated Revolving Note dated June 12, 2024 (Filed With SEC on June 18, 2024)
- Term Loan Note dated June 12, 2024 (Filed With SEC on June 18, 2024)
- Consent, Joinder and Amendment No. 5 to Loan and Security Agreement dated June 12, 2024, between the Company, the Obligors and lenders party thereto and Eclipse Business Capital... (Filed With SEC on June 18, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on June 5, 2023)
- Form of Tranche B Warrant (Filed With SEC on June 5, 2023)
- Form of Tranche A Warrant (Filed With SEC on June 5, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on June 5, 2023)
- Second Amendment to Loan Documents by and among Avenue Capital Management II L.P., certain lenders and Aytu BioPharma, Inc., dated March 24, 2023 (Filed With SEC on May 11, 2023)
- Amendment No. 4 to Loan and Security Agreement by and among Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos Therapeutics Commercial, LLC,... (Filed With SEC on May 11, 2023)
- Form of Common Warrant (Filed With SEC on August 10, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 10, 2022)
- Underwriting Agreement dated August 9, 2022 (Filed With SEC on August 10, 2022)
- Form of Common Stock Purchase Warrant (Filed With SEC on March 4, 2022)
- Form of Prefunded Common Stock Purchase Warrant (Filed With SEC on March 4, 2022)
- Underwriting Agreement, dated as of March 2, 2022, by and between Aytu BioPharma, Inc. and Canaccord Genuity LLC (Filed With SEC on March 4, 2022)
- Loan and Security Agreement dated January 26, 2022 between the registrant and the Avenue Capital Lenders and Avenue Capital Agent (Filed With SEC on February 14, 2022)
- Restricted Stock Award Agreement between Aytu BioPharma, Inc. and Mark Oki, effective January 17, 2022 (Filed With SEC on February 14, 2022)
- Closing Certificate with respect to the July 1, 2021 Asset Purchase Agreement, dated September 29, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on November 15, 2021)
- Promissory Note, dated September 29, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on November 15, 2021)
- Asset Purchase Agreement, dated July 1, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on September 28, 2021)
- Asset Purchase Agreement, dated April 12, 2021 (Filed With SEC on May 17, 2021)
- Consent, Waiver and Amendment No. 1 to Loan and Security Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics,... (Filed With SEC on March 22, 2021)
- Consent, Waiver and Sixth Amendment to Facility Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos... (Filed With SEC on March 22, 2021)
- Amended and Restated Underwriting Agreement, dated December 10, 2020, between Aytu BioScience, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 14, 2020)
- Commitment Letter, dated as of December 10, 2020, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc. and Encina Business Credit, LLC (Filed With SEC on December 10, 2020)
- Form of Restricted Stock Cancelation and Exchange Agreement (Filed With SEC on July 2, 2020)
- Form of Wainwright Warrant (Filed With SEC on July 2, 2020)
- Form of Securities Purchase Agreement, dated March 12, 2020, by and between the Company and the Purchaser (Filed With SEC on March 20, 2020)
- Form of Warrant (Filed With SEC on March 20, 2020)
- Form of Securities Purchase Agreement, dated March 12, 2020, by and between the Company and the Purchaser (Filed With SEC on March 13, 2020)
- Form of Warrant (Filed With SEC on March 13, 2020)
- Form of Securities Purchase Agreement, dated March 10, 2020, by and between the Company and the Purchaser (Filed With SEC on March 13, 2020)
- Form of Pre-Funded Purchase Warrant (Filed With SEC on March 13, 2020)
- Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 7, 2019)
- Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
- Form of Security Holder Voting Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
- Registration Rights Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
- First Amendment to Asset Purchase Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
- Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
- Asset Purchase Agreement, dated October 10, 2019 (Filed With SEC on October 15, 2019)